Published by Frank Prenesti on 9th May 2023
(Sharecast News) - AstraZeneca's Farxiga drug has been approved in the US to reduce the risk of cardiovascular death, hospitalisation for heart failure and urgent heart failure visits in adults, the company said on Tuesday.
URL: http://www.digitallook.com/dl/news/story/33488055/...